← All earnings call summaries
PI Industries Limited — Q1FY27 Earnings Call Summary
Key Takeaways
- New molecule pipeline includes ~90 projects; 4-5 product launches planned in FY27
- Pioxaniliprole insecticide launch expected in India within FY27; global launches later
- Capex guidance Rs 700-800 crore for FY27; investments in manufacturing and innovation
- Q1 FY27 revenue Rs 17,023 million; gross margin 57%, EBITDA margin 22%
- Export business challenged by global industry downturn; recovery expected H2 FY27
- Domestic agrochem volume grew 12%, biologicals up 50% with 3-year CAGR 15%
- Management confident on medium-term growth despite near-term pricing pressures
- Pharma CRDMO business in early stage; long gestation with investments ongoing
- Biological nematicide registered in Brazil, Mexico, US; unique foliar application
- Net working capital reduced by 19 days, releasing Rs 300 crore cash; net cash Rs 38 billion
📄 Source: View original transcript (PDF)
Get PI Industries Limited earnings summaries on Telegram
Add PI Industries Limited to your watchlist. Receive AI-generated summaries within hours of every earnings call.
Start free →
Summary generated by AI from the official transcript filed on BSE/NSE. Not investment advice.